RVMD - Revolution Medicines GAAP EPS of -$0.92 misses by $0.09 revenue of $3.82M beats by $2.26M August, 08 2023 04:34 PM Revolution Medicines Inc. 2023-08-08 16:34:19 ET Revolution Medicines press release ( NASDAQ: RVMD ): Q2 GAAP EPS of -$0.92 misses by $0.09 . Revenue of $3.82M (-58.1% Y/Y) beats by $2.26M . For further details see: Revolution Medicines GAAP EPS of -$0.92 misses by $0.09, revenue of $3.82M beats by $2.26M